MedTrace Logo

Visual Reconstitution Therapy After Optic Neuritis

NCT01274702 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2021-07-29

No results posted yet for this study

Summary

Incomplete remission after an optic neuritis attack is not uncommon. Visual reconstitution therapy is a software-based approach that has been shown to substantially improve residual visual field deficits in patients with pre- and postchiasmatic lesions.

The primary hypothesis of this randomized, controlled clinical trial is, that visual reconstitution therapy is superior to active comparator treatment in improving the visual field after optic neuritis.

Conditions

Interventions

OTHER

Visual Reconstitutions Therapy

OTHER

Saccadic Eye Movement Training

Sponsors & Collaborators

  • Beuth Hochschule für Technik Berlin

    collaborator UNKNOWN

  • NovaVision AG, Zentrum für Sehtherapie

    collaborator UNKNOWN

  • Friedemann Paul

    lead OTHER

Principal Investigators

  • Friedemann Paul, MD · NeuroCure Clinical Research Center, Charité Universitaetsmedizin Berlin

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2013-03-31
Completion
2013-03-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01274702 on ClinicalTrials.gov